rs2303568
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000141.5(FGFR2):c.454+54T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0268 in 1,521,000 control chromosomes in the GnomAD database, including 5,241 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.11 ( 2639 hom., cov: 32)
Exomes 𝑓: 0.018 ( 2602 hom. )
Consequence
FGFR2
NM_000141.5 intron
NM_000141.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.229
Publications
6 publications found
Genes affected
FGFR2 (HGNC:3689): (fibroblast growth factor receptor 2) The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009]
FGFR2 Gene-Disease associations (from GenCC):
- Apert syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, PanelApp Australia, G2P, Genomics England PanelApp
- Beare-Stevenson cutis gyrata syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Genomics England PanelApp
- Crouzon syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, ClinGen, PanelApp Australia, Genomics England PanelApp, G2P
- Jackson-Weiss syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P
- LADD syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Pfeiffer syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
- Antley-Bixler syndrome without genital anomalies or disordered steroidogenesisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, G2P
- bent bone dysplasia syndrome 1Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- familial scaphocephaly syndrome, McGillivray typeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- Saethre-Chotzen syndromeInheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp
- Antley-Bixler syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- LADD syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 2Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Pfeiffer syndrome type 3Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 10-121564448-A-G is Benign according to our data. Variant chr10-121564448-A-G is described in ClinVar as Benign. ClinVar VariationId is 1221381.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.341 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FGFR2 | ENST00000358487.10 | c.454+54T>C | intron_variant | Intron 4 of 17 | 1 | NM_000141.5 | ENSP00000351276.6 | |||
| FGFR2 | ENST00000457416.7 | c.454+54T>C | intron_variant | Intron 4 of 17 | 1 | ENSP00000410294.2 | ||||
| FGFR2 | ENST00000369056.5 | c.454+54T>C | intron_variant | Intron 3 of 16 | 1 | ENSP00000358052.1 | ||||
| FGFR2 | ENST00000369058.7 | c.454+54T>C | intron_variant | Intron 4 of 16 | 1 | ENSP00000358054.3 | ||||
| FGFR2 | ENST00000613048.4 | c.187+54T>C | intron_variant | Intron 3 of 16 | 5 | ENSP00000484154.1 | ||||
| FGFR2 | ENST00000369061.8 | c.454+54T>C | intron_variant | Intron 3 of 14 | 1 | ENSP00000358057.4 | ||||
| FGFR2 | ENST00000369059.5 | c.110-12989T>C | intron_variant | Intron 2 of 15 | 5 | ENSP00000358055.1 | ||||
| FGFR2 | ENST00000360144.7 | c.187+54T>C | intron_variant | Intron 3 of 16 | 2 | ENSP00000353262.3 | ||||
| FGFR2 | ENST00000604236.5 | n.110-12989T>C | intron_variant | Intron 2 of 16 | 1 | ENSP00000474109.1 |
Frequencies
GnomAD3 genomes AF: 0.110 AC: 16661AN: 151838Hom.: 2621 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
16661
AN:
151838
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0175 AC: 24014AN: 1369042Hom.: 2602 Cov.: 22 AF XY: 0.0154 AC XY: 10543AN XY: 686418 show subpopulations
GnomAD4 exome
AF:
AC:
24014
AN:
1369042
Hom.:
Cov.:
22
AF XY:
AC XY:
10543
AN XY:
686418
show subpopulations
African (AFR)
AF:
AC:
11277
AN:
31534
American (AMR)
AF:
AC:
4728
AN:
44634
Ashkenazi Jewish (ASJ)
AF:
AC:
18
AN:
25638
East Asian (EAS)
AF:
AC:
2863
AN:
39254
South Asian (SAS)
AF:
AC:
291
AN:
84476
European-Finnish (FIN)
AF:
AC:
1503
AN:
52186
Middle Eastern (MID)
AF:
AC:
117
AN:
5276
European-Non Finnish (NFE)
AF:
AC:
1357
AN:
1028712
Other (OTH)
AF:
AC:
1860
AN:
57332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1101
2202
3304
4405
5506
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
424
848
1272
1696
2120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.110 AC: 16727AN: 151958Hom.: 2639 Cov.: 32 AF XY: 0.109 AC XY: 8132AN XY: 74274 show subpopulations
GnomAD4 genome
AF:
AC:
16727
AN:
151958
Hom.:
Cov.:
32
AF XY:
AC XY:
8132
AN XY:
74274
show subpopulations
African (AFR)
AF:
AC:
14296
AN:
41358
American (AMR)
AF:
AC:
1344
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
3
AN:
3472
East Asian (EAS)
AF:
AC:
374
AN:
5154
South Asian (SAS)
AF:
AC:
36
AN:
4782
European-Finnish (FIN)
AF:
AC:
320
AN:
10606
Middle Eastern (MID)
AF:
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
AC:
178
AN:
67998
Other (OTH)
AF:
AC:
173
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
561
1123
1684
2246
2807
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
199
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 25, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.